Source: FinanzNachrichten

Stellar Biotechnologies: Stellar Biotechnologies to Present at Biotech Showcase Conference

LOS ANGELES, CA -- (Marketwired) -- 01/04/17 -- Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targe...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100